Form 8-K - Current report:
SEC Accession No. 0001144204-16-128033
Filing Date
2016-10-13
Accepted
2016-10-13 17:15:20
Documents
3
Period of Report
2016-10-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v450493_8k.htm 8-K 18912
2 EXHIBIT 10.1 v450493_ex10-1.htm EX-10.1 124992
3 EXHIBIT 10.2 v450493_ex10-2.htm EX-10.2 30329
  Complete submission text file 0001144204-16-128033.txt   175464
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 161935477
SIC: 2834 Pharmaceutical Preparations